rs111439115
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_012452.3(TNFRSF13B):c.754G>A(p.Asp252Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000503 in 1,611,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_012452.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNFRSF13B | NM_012452.3 | c.754G>A | p.Asp252Asn | missense_variant | 5/5 | ENST00000261652.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNFRSF13B | ENST00000261652.7 | c.754G>A | p.Asp252Asn | missense_variant | 5/5 | 1 | NM_012452.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000685 AC: 17AN: 248324Hom.: 0 AF XY: 0.0000521 AC XY: 7AN XY: 134440
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1458956Hom.: 0 Cov.: 37 AF XY: 0.0000262 AC XY: 19AN XY: 725308
GnomAD4 genome AF: 0.000276 AC: 42AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.000229 AC XY: 17AN XY: 74324
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2023 | This variant has not been reported in the literature in individuals affected with TNFRSF13B-related conditions. This variant is present in population databases (rs111439115, gnomAD 0.08%). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 252 of the TNFRSF13B protein (p.Asp252Asn). ClinVar contains an entry for this variant (Variation ID: 538708). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TNFRSF13B protein function. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 05, 2022 | The c.754G>A (p.D252N) alteration is located in exon 5 (coding exon 5) of the TNFRSF13B gene. This alteration results from a G to A substitution at nucleotide position 754, causing the aspartic acid (D) at amino acid position 252 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at